tenk.fyi

MiNK Therapeutics, Inc.

INKTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$12.5M

15.9% YoY

EPS

$-2.93

2.4% YoY

Cash

$13.4M

191.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro